{"abstract": "In an move to target the many adults who have not been vaccinated against hepatitis B, Merck has licensed a new, potentially more powerful vaccine against the disease. ", "web_url": "https://www.nytimes.com/2007/11/01/business/01vaccine.html", "snippet": "In an move to target the many adults who have not been vaccinated against hepatitis B, Merck has licensed a new, potentially more powerful vaccine against the disease. ", "lead_paragraph": "Merck has licensed the exclusive worldwide rights to sell a new, potentially more powerful vaccine against hepatitis B from Dynavax Technologies Corporation, a biotechnology company that is exploiting new findings about how the immune system works. ", "print_section": "C", "print_page": "11", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck Buys License to Sell New Vaccine for Hepatitis", "kicker": null, "content_kicker": null, "print_headline": "Merck Buys License to Sell New Vaccine for Hepatitis", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Vaccination and Immunization", "rank": 3, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 4, "major": "N"}], "pub_date": "2007-11-01T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/0e1ea81f-d1d9-54d9-885d-cc5e7c3d348a", "word_count": 360, "uri": "nyt://article/0e1ea81f-d1d9-54d9-885d-cc5e7c3d348a"}